PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
XGEN.DE vs. IEUX.AS
Performance
Return for Risk
Dividends
Drawdowns
Volatility

XGEN.DE vs. IEUX.AS

Last updated Apr 2, 2026

Compare and contrast key facts about Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS).

XGEN.DE and IEUX.AS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XGEN.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. It was launched on Jul 12, 2022. IEUX.AS is a passively managed fund by iShares that tracks the performance of the MSCI Europe Ex UK NR EUR. It was launched on Jun 2, 2006. Both XGEN.DE and IEUX.AS are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

XGEN.DE vs. IEUX.AS - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

XGEN.DE vs. IEUX.AS - Yearly Performance Comparison

2026 (YTD)2025202420232022
XGEN.DE
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C		-4.14%7.38%2.95%-5.84%-9.98%
IEUX.AS
iShares MSCI Europe ex-UK UCITS ETF		-0.16%19.55%7.52%17.22%1.58%

Returns By Period

In the year-to-date period, XGEN.DE achieves a -4.14% return, which is significantly lower than IEUX.AS's -0.16% return.

XGEN.DE

1D
2.28%
1M
-1.91%
YTD
-4.14%
6M
5.14%
1Y
11.86%
3Y*
0.68%
5Y*
—
10Y*
—

IEUX.AS

1D
2.64%
1M
-4.03%
YTD
-0.16%
6M
5.11%
1Y
11.63%
3Y*
11.08%
5Y*
8.71%
10Y*
9.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

iShares MSCI Europe ex-UK UCITS ETF

Often compared with XGEN.DE:
XGEN.DE vs. IDNAXGEN.DE vs. WRNA.DEXGEN.DE vs. OG35.DEXGEN.DE vs. XDWH.DEXGEN.DE vs. ESGL.LXGEN.DE vs. GLDXGEN.DE vs. FBT.L
Often compared with IEUX.AS:
IEUX.AS vs. VGKIEUX.AS vs. VUSA.ASIEUX.AS vs. GLDIEUX.AS vs. SPYIEUX.AS vs. IAEX.ASIEUX.AS vs. ICHN.ASIEUX.AS vs. IMEU.AS

XGEN.DE vs. IEUX.AS - Expense Ratio Comparison

XGEN.DE has a 0.30% expense ratio, which is lower than IEUX.AS's 0.40% expense ratio.

IEUX.AS
iShares MSCI Europe ex-UK UCITS ETF
XGEN.DE
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

Return for Risk

XGEN.DE vs. IEUX.AS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
XGEN.DE
XGEN.DE Risk / Return Rank: 3030
Overall Rank
XGEN.DE Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
XGEN.DE Sortino Ratio Rank: 2828
Sortino Ratio Rank
XGEN.DE Omega Ratio Rank: 2626
Omega Ratio Rank
XGEN.DE Calmar Ratio Rank: 3434
Calmar Ratio Rank
XGEN.DE Martin Ratio Rank: 3030
Martin Ratio Rank
IEUX.AS
IEUX.AS Risk / Return Rank: 5050
Overall Rank
IEUX.AS Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
IEUX.AS Sortino Ratio Rank: 3434
Sortino Ratio Rank
IEUX.AS Omega Ratio Rank: 3535
Omega Ratio Rank
IEUX.AS Calmar Ratio Rank: 7373
Calmar Ratio Rank
IEUX.AS Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XGEN.DE vs. IEUX.AS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

XGEN.DEIEUX.ASDifference

Sharpe ratio

Return per unit of total volatility

0.57

0.74

-0.17

Sortino ratio

Return per unit of downside risk

0.89

1.05

-0.16

Omega ratio

Gain probability vs. loss probability

1.11

1.16

-0.04

Calmar ratio

Return relative to maximum drawdown

0.97

2.13

-1.16

Martin ratio

Return relative to average drawdown

2.79

8.44

-5.65

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XGEN.DE vs. IEUX.AS - Sharpe Ratio Comparison

The current XGEN.DE Sharpe Ratio is 0.57, which is comparable to the IEUX.AS Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of XGEN.DE and IEUX.AS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

XGEN.DEIEUX.ASDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.57

0.74

-0.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

—

0.59

—

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.57

—

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.15

0.28

-0.43

Correlation

The correlation between XGEN.DE and IEUX.AS is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

XGEN.DE vs. IEUX.AS - Dividend Comparison

XGEN.DE has not paid dividends to shareholders, while IEUX.AS's dividend yield for the trailing twelve months is around 2.13%.

TTM20252024202320222021202020192018201720162015
XGEN.DE
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IEUX.AS
iShares MSCI Europe ex-UK UCITS ETF		2.13%2.15%2.36%2.37%2.34%1.62%1.43%2.33%2.65%2.27%2.31%2.16%

Drawdowns

XGEN.DE vs. IEUX.AS - Drawdown Comparison

The maximum XGEN.DE drawdown since its inception was -37.58%, smaller than the maximum IEUX.AS drawdown of -60.28%. Use the drawdown chart below to compare losses from any high point for XGEN.DE and IEUX.AS.

Loading graphics...

Drawdown Indicators

XGEN.DEIEUX.ASDifference

Max Drawdown

Largest peak-to-trough decline

-37.58%

-60.28%

+22.70%

Max Drawdown (1Y)

Largest decline over 1 year

-14.88%

-12.05%

-2.83%

Max Drawdown (5Y)

Largest decline over 5 years

—

-22.47%

—

Max Drawdown (10Y)

Largest decline over 10 years

—

-34.79%

—

Current Drawdown

Current decline from peak

-17.22%

-5.85%

-11.37%

Average Drawdown

Average peak-to-trough decline

-19.46%

-14.79%

-4.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.61%

2.51%

+2.10%

Volatility

XGEN.DE vs. IEUX.AS - Volatility Comparison

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS) have volatilities of 6.10% and 6.02%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

XGEN.DEIEUX.ASDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.10%

6.02%

+0.08%

Volatility (6M)

Calculated over the trailing 6-month period

13.02%

9.53%

+3.49%

Volatility (1Y)

Calculated over the trailing 1-year period

20.88%

15.58%

+5.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.50%

14.75%

+3.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.50%

15.65%

+2.85%